Login / Signup

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Riikka KarjalainenMinxia LiuAshwini KumarLiye HeDisha MalaniAlun ParsonsMika KontroOlli KallioniemiKimmo PorkkaCaroline A Heckman
Published in: Leukemia (2019)
Keyphrases
  • poor prognosis
  • acute myeloid leukemia
  • chronic lymphocytic leukemia
  • binding protein
  • allogeneic hematopoietic stem cell transplantation
  • long non coding rna
  • acute lymphoblastic leukemia